Curanex Pharmaceuticals Inc
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $60.1K | — |
| FY2024 | — | $503.4K | — |
| FY2025 | — | $11.2M | $5.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $60.1K | — |
| FY2024 | — | $503.4K | — |
| FY2025 | — | $11.2M | $5.0M |